Disclosure Of Fair Value Measurement [Text Block]

Hyloris Pharmaceuticals SA - Filing #3166138

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
47,681 EUR
60,728 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
8,613 EUR
6,819 EUR
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
39,069 EUR
80,761 EUR
476,000 EUR
121,513 EUR
140,000 EUR
4,460 EUR
2,162 EUR
53,909 EUR
1,136 EUR
140,000 EUR
121,513 EUR
476,000 EUR
476,000 EUR
1,622 EUR
1,136 EUR
4,460 EUR
4,460 EUR
121,513 EUR
1,622 EUR
65,381 EUR
64,246 EUR
140,000 EUR
55,045 EUR
54,805 EUR
476,000 EUR
48,056 EUR
3,827 EUR
103,693 EUR
2,391 EUR
129,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.